RESEARCH PROTOCOL: Diabetes Management and Outcomes Study

PRINCIPAL INVESTIGATOR: Dr. Michael Chen, MD, PhD
Department of Endocrinology, Medical Research Institute

STUDY TITLE: Comparative Effectiveness of Diabetes Management Strategies

INFORMED CONSENT:
All participants will receive comprehensive informed consent documentation including:
- Detailed explanation of study objectives and procedures
- Clear description of potential risks and benefits
- Explicit statement of voluntary participation
- Right to withdraw at any time without consequences
- Comprehensive privacy and confidentiality protections
- Contact information for study team and IRB

DATA SECURITY AND PRIVACY PROTECTION:
- HIPAA-compliant data storage and transmission
- End-to-end encryption for all data
- Role-based access controls
- Regular security assessments and penetration testing
- Data anonymization and de-identification protocols
- Secure data retention and disposal procedures

RISK ASSESSMENT:
Potential risks include:
- Minor discomfort from blood glucose monitoring
- Time commitment for study visits and data collection
- Potential privacy concerns (adequately mitigated)
- Minimal risk of data breach (comprehensive security measures)

Benefits include:
- Comprehensive diabetes health assessments
- Potential improvements in diabetes management
- Contribution to diabetes research and treatment
- Financial compensation for participation

VOLUNTARY PARTICIPATION:
Participation in this study is completely voluntary. Participants have the right to withdraw at any time without penalty or loss of benefits to which they are otherwise entitled.

CONFIDENTIALITY AND PRIVACY:
All participant data will be kept strictly confidential. Personal identifiers will be removed and replaced with unique study codes. Data will be stored in secure, encrypted systems.

STUDY OBJECTIVES:
This study aims to compare the effectiveness of different diabetes management strategies on glycemic control and long-term outcomes in patients with Type 2 diabetes.

TARGET POPULATION:
- Patients aged 21-80 years
- Diagnosed with Type 2 diabetes mellitus (ICD-10: E11)
- Both male and female participants
- Active patients with regular follow-up care

DATA REQUIREMENTS:
- Patient demographics and medical history
- Diabetes diagnosis and duration
- Glycemic control measurements (HbA1c, blood glucose)
- Medication history and adherence
- Comorbid conditions and complications
- Treatment outcomes and adverse events

RESOURCE TYPES NEEDED:
- Patient: Demographics, age, gender, active status
- Condition: Diabetes diagnoses, clinical status, complications
- Observation: HbA1c, blood glucose, lab values
- MedicationRequest: Diabetes medications, insulin
- Procedure: Diabetes-related procedures
- Encounter: Clinical visits and follow-ups

FILTERS AND CRITERIA:
- Age range: 21-80 years
- Gender: All (male and female)
- Conditions: Type 2 diabetes mellitus (SNOMED: 44054006)
- Date range: 2019-01-01 to 2025-12-31
- Target patient count: 300 patients

MONITORING AND OVERSIGHT:
- Regular IRB review and approval
- Independent data safety monitoring board
- Quarterly progress reports
- Comprehensive adverse event reporting
- Annual study audits 